Virtus ETF Advisers’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $80.1K | Hold |
4,396
| – | – | 0.11% | 157 |
|
|
2025
Q1 | $87.2K | Sell |
4,396
-14,332
| -77% | -$284K | 0.11% | 159 |
|
|
2024
Q4 | $321K | Sell |
18,728
-11,824
| -39% | -$203K | 0.13% | 236 |
|
|
2024
Q3 | $611K | Hold |
30,552
| – | – | 0.29% | 177 |
|
|
2024
Q2 | $342K | Sell |
30,552
-63,760
| -68% | -$713K | 0.17% | 202 |
|
|
2024
Q1 | $622K | Buy |
94,312
+13,569
| +17% | +$89.6K | 0.33% | 155 |
|
|
2023
Q4 | $365K | Buy |
80,743
+2,519
| +3% | +$11.4K | 0.23% | 180 |
|
|
2023
Q3 | $280K | Sell |
78,224
-10,111
| -11% | -$36.2K | 0.17% | 208 |
|
|
2023
Q2 | $326K | Buy |
88,335
+4,410
| +5% | +$16.3K | 0.19% | 180 |
|
|
2023
Q1 | $278K | Buy |
83,925
+1,486
| +2% | +$4.92K | 0.15% | 256 |
|
|
2022
Q4 | $320K | Buy |
+82,439
| New | +$320K | 0.17% | 240 |
|